Ono Pharma Foundation

Ono Pharma Foundation is a specialized nonprofit organization dedicated to advancing academic research within critical scientific domains, specifically focusing on therapeutic approaches for disease and pain management. Established as an independent entity, the foundation maintains a deep historical connection to Ono Pharmaceutical Co., a global healthcare leader with origins dating back to 1717 in Japan. By fostering an environment conducive to high-impact scientific discovery, the foundation serves as a bridge between foundational academic inquiry and the practical development of breakthrough medical treatments.

The organization operates the Ono Pharma Breakthrough Science Initiative Awards Program, which provides competitive grants to researchers pursuing high-risk, high-reward projects. This initiative is designed to catalyze innovation by supporting creative ideas that possess the potential to transform current therapeutic paradigms. The foundation’s operational framework relies on a dedicated group of professionals who manage grant distribution and scientific evaluation. Meet Ono Pharma Foundation's team to understand the leadership and expertise driving these strategic research investments. Their commitment to open innovation ensures that promising scientific concepts receive the necessary resources to progress toward clinical application.

Operating from its base in Lawrenceville, New Jersey, the foundation maintains a significant presence in the North American research ecosystem. With 1,000-5,000 employees, the organization leverages its scale to influence drug discovery and patient care outcomes. While competing in a landscape populated by entities like Catalent, Incyte, and Charles River, the foundation distinguishes itself through its non-profit mission and focus on early-stage, high-potential research. By prioritizing scientific excellence over immediate commercial returns, Ono Pharma Foundation continuesView more...